Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 203 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
203
Total Funding
$1.4B
Avg Funding
$54.3M
Cities
23

Export 203 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boca Raton, United States
$900K
raised

Smart for Life markets and manufactures nutritional foods and supplements for the global nutraceutical marketplace.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pompano Beach, United States
$2.5M
raised

BioStem Technologies is engaged in the advancement of regenerative medicine and antiaging strategies.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Durham, United States
$12.6M
raised

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments.

May 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$67.8M
raised

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$60.0M
raised

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Palm Beach Gardens, United States
$3.8M
raised

Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Macclesfield, United Kingdom
$43.6M
raised

Redx Pharma is a drug discovery and development company.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$115.0M
raised

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Calgary, Canada
$5.0M
raised

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dallas, United States
$4.4M
raised

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Perth, Australia
$2.5M
raised

Emria is a data-backed drug development and care delivery company.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Warren, United States
$3.0M
raised

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pennsylvania Furnace, United States
$250.0M
raised

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$2.6M
raised

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

May 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sherman Oaks, United States
$150.0M
raised

Forte Biosciences is a biotechnology company that focuses on dermatology.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Dublin, Ireland
$117.5M
raised

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States
$384.4M
raised

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Austin, United States
$4.8M
raised

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$4.1M
raised

New treatment for blood diseases, such as leukemia and lymphoma.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redmond, United States
$110.0M
raised

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Corona, United States
$3.0M
raised

Ikänik Farms is engaged in cultivation, manufacturing, retail, and global distribution of cannabis and hemp CBD.

Apr 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden
$3.3M
raised

The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Baltimore, United States
$1.0M
raised

Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rockville, United States
$5.3M
raised

OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$428K
raised

A health sciences company that develops innovative options for preventive and curative therapies .

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 203 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 203 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked